Adherence, Medication Clinical Trial
— COPAPI-GOfficial title:
Concordance : a New Concept for Clinical Pharmacy in Partnership With Patients at a Geriatric Day Clinic
The goal of this clinical trial is to assess the impact of pharmaceutical consultations in older patients having a comprehensive geriatric assessment at geriatric day-clinic. The main question it aims to answer is: What is the impact on patient adherence Participants will benefit from medication history taking, medication review, therapeutic education, shared decision-making and follow-up phone call. Researchers will compare with a control group, benefiting from medication history taking and usual care from the geriatric day-clinic.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | November 1, 2024 |
Est. primary completion date | September 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 75 Years to 125 Years |
Eligibility | Inclusion Criteria: - 75+ - patients admitted to the geriatric day hospital for a geriatric assessment will be eligible for the project. A geriatric assessment comprises 2 consultations at the geriatric day hospital: a "major assessment" consultation, where the patient meets the members of the multidisciplinary team, and a "results" consultation, where the geriatrician provides the patient with care recommendations. Exclusion Criteria: - less than 75 - not speaking French - exlusion based on geriatrician advice |
Country | Name | City | State |
---|---|---|---|
Belgium | Cliniques universitaires Saint-Luc | Bruxelles |
Lead Sponsor | Collaborator |
---|---|
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | presence of barriers to adherence as measured by ASK-20 score (the sum of raw ASK-20 item scores) | ASK-20 (questionnaire) consists of 20 clinically actionable items representing multiple factors that affect medication adherence. Each of the 20 items score from 1 to 5. A score of 20 means low barriers to adherence; A score of 100 means maximum barriers to adherence. Comparizon of ASK-20 score from baseline to 6weeks in both arms. Hahn SR, Park J, Skinner EP, Yu-Isenberg KS, Weaver MB, Crawford B, Flowers PW. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008 Jul;24(7):2127-38. doi: 10.1185/03007990802174769. Epub 2008 Jun 12. PMID: 18554431. | 6weeks | |
Secondary | count of barriers to adherence measured by TBC ASK-20 (Total Barrier Count) | Each of the 20 items Of the ASK-20 (questionnaire) was dichotomized as positive - indicating a barrier, or negative. TBC counts the barriers per patient. Comparison of TBC from baseline to 6 weeks in both arms. Hahn SR, Park J, Skinner EP, Yu-Isenberg KS, Weaver MB, Crawford B, Flowers PW. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008 Jul;24(7):2127-38. doi: 10.1185/03007990802174769. Epub 2008 Jun 12. PMID: 18554431. | 6weeks | |
Secondary | quality of life measured with EQ5D (Visual analogical scale) score | Quality of life questionnaire. Comparison of estimated quality of life between baseline and 6 weeks in both arms | 6weeks | |
Secondary | number of inappropriate medications per patient according to STOPP/START | Detection od potentially inappropriate medications (PIM) using STOPP&START version 2 in medication treatment and comparison of number of PIM between baseline and 6 weeks in both arms | 6weeks | |
Secondary | number of Drug-drug interactions per patient from the Anrys list | Comparison in both arms of drug-drug interactions detected at baseline and 6 weeks in medication treatment according to Anrys et al. Anrys P, Spinewine A. An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People: Clinical Utility? J Am Med Dir Assoc. 2022 Mar;23(3):522. doi: 10.1016/j.jamda.2021.11.038. Epub 2022 Jan 10. PMID: 35026145. | 6weeks | |
Secondary | pain severity (from EQ-D) | Comparison of pain reported in EQ5D questionnaire from baseline to 6 weeks in both groups | 6weeks | |
Secondary | number of hospital admissions reported by patient | comparison of reported hospitalisations in both groups during the study period (questionnaire) | 6weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05546931 -
Mobile Health Program for Rural Hypertension
|
N/A | |
Recruiting |
NCT04316715 -
Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care
|
N/A | |
Active, not recruiting |
NCT04602468 -
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
|
Phase 4 | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Enrolling by invitation |
NCT04676204 -
Relationship Between Oral DMT Burden and Adherence in MS
|
||
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Completed |
NCT05168449 -
The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients
|
N/A | |
Active, not recruiting |
NCT04612088 -
Intervention for Multivitamin Adherence on Bariatric Patients
|
N/A | |
Completed |
NCT03958331 -
Behavioral Economics and Adherence in Teens (BEAT!)
|
N/A | |
Completed |
NCT05233644 -
Medication Adherence in Heart Failure After Hospitalisation
|
||
Completed |
NCT03837496 -
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03683966 -
MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
|
||
Withdrawn |
NCT04754867 -
Pre-Test of For the Future Self and Smoking Cessation
|
N/A | |
Recruiting |
NCT05996094 -
Antiretroviral Adherence and Drug-level Monitoring
|
||
Not yet recruiting |
NCT06056037 -
Making ART Work Among Brazilian Youth
|
N/A | |
Completed |
NCT03651596 -
Leveraging mHealth Messaging to Promote Adherence in Teens With CKD
|
N/A | |
Completed |
NCT03658252 -
Efficacy of Targeted Intervention for Topical Steroid Phobia.
|
N/A | |
Completed |
NCT03842436 -
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use
|
Phase 4 | |
Completed |
NCT03081559 -
Improving Engagement in HIV Care for High-risk Women
|
N/A | |
Recruiting |
NCT05515497 -
BMT4me: Post-HSCT Medication Adherence mHealth App
|
N/A |